Blood Substitutes and Oxygen Therapeutics: A Review
Publication Date
2021
Journal Title
Anesth Analg
Abstract
Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers have succeeded in providing a reasonable alternative to allogeneic blood transfusion. However, there remain scenarios in which blood transfusion is not an option, due to patient's religious beliefs, inability to find adequately cross-matched erythrocytes, or in remote locations. In these situations, artificial oxygen carriers may provide a mortality benefit for patients with severe, life-threatening anemia. This article provides an up-to-date review of the history and development, clinical trials, new technology, and current standing of artificial oxygen carriers as an alternative to transfusion when blood is not an option.
Volume Number
132
Issue Number
1
Pages
119 - 129
Document Type
Article
Status
Faculty
Facility
School of Medicine
Primary Department
Anesthesiology
PMID
DOI
10.1213/ANE.0000000000003957